Ghost Tree Capital »

Cg Oncology shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.2M 260k 31.57
2024-03-31 $3.3M 75k 43.90

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
Braidwell
BVF
Vanguard Group
BlackRock
Henderson Group
RA Capital Management
Avidity Partners Management
Franklin Resources
Alliancebernstein
State Street Corporation
Cormorant Asset Management
Frazier Life Sciences Management
Perceptive Advisors

View all funds holding Cg Oncology